⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Crown Bioscience and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Crown Bioscience
↗San Diego, California, USA
Crown Bioscience is a global contract research organization (CRO) specializing in preclinical and translational oncology and immuno-oncology drug discovery. The company provides a comprehensive suite of services, including in vivo, in vitro, and ex vivo models, to help pharmaceutical and biotechnology companies accelerate their drug development programs.
As a division of JSR Life Sciences, Crown Bioscience leverages a vast portfolio of proprietary platforms, including the world's largest commercially available patient-derived xenograft (PDX) collection and advanced organoid models. The company focuses on de-risking drug development by providing high-quality, human-relevant data to guide clinical translation and patient stratification.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:2006
Ownership:subsidiary
Status:operating
FUNDING
Total Raised:$85.9M
Investors:Orbimed, The CID Group, Qiming Venture Partners
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (CRO)
Modalities:Small molecule, mAb, ADC, Cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:JSR Corporation
Acquired By:JSR Corporation (2018-01-01)
Subsidiaries:Crown Bioscience UK Ltd, Crown Bioscience San Diego
Key Partnerships:C-Path (NAMs-DC), Turbine (AI-driven prediction), Hubrecht Organoid Technology
COMPETITION
Position:Leader
Competitors:Charles River Laboratories, Labcorp, WuXi AppTec, Eurofins
LEADERSHIP
Key Executives:
John Gu - CEO and COO
Zhaoxue (Luke) Yu - SVP, Global Scientific Operations
LINKS
Website:crownbio.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Crown Bioscience. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.